Status:

WITHDRAWN

Sevoflurane- Safety in Long-term Sedation Procedures

Lead Sponsor:

F Javier Belda

Conditions:

Poisoning by Inhaled Anaesthetic

Fluoride Poisoning

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Patients needing intensive care often require sedative drugs to reduce anxiety and agitation during ventilator care and invasive therapeutic and diagnostic procedures. At present there is no optimal s...

Eligibility Criteria

Inclusion

  • Signing of the informed consent document (patient or relatives).
  • Patient age 18 years or older.
  • Expected minimum duration of sedation: 48 hours.

Exclusion

  • Chronic renal failure treated with replacement therapy (hemodialysis or peritoneal dialysis).
  • Acute kidney injury in Stage 3 of AKIN classification
  • Grade C hepatic Child-Pugh classification
  • Established Acute Respiratory Distress Syndrome (ARDS).
  • Central nervous system pathology with cognitive disorders that not allow performing the test of the study: severe dementia, Alzheimer's disease, depression, schizophrenia, acute stroke.
  • Head trauma with Glasgow \<12.
  • Patient treated with antiepileptic drugs that must be maintained during the study period
  • Patients requiring the use of neuromuscular blocking agents during the infusion of study drug, except for the insertion of the endotracheal tube.
  • Epidural or spinal analgesia
  • Allergy or known hypersensitivity to any of the study drugs
  • Patients with known or suspected genetic susceptibility to malignant hyperthermia
  • Previous participation in this trial
  • Participation in another clinical trial within 4 weeks prior to selection.
  • Pregnant women

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01802255

Start Date

March 1 2013

End Date

June 1 2015

Last Update

August 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Clínico Universitario de Valencia

Valencia, Spain, 46010